A Taiwanese nationwide cohort study of more than 10,000 patients with chronic hepatitis B showed a statistically significant 29% risk reduction for hepatocellular carcinoma in patients who received daily aspirin compared with matched controls.
Monotherapy for inflammatory bowel disease (IBD) with an immunosuppressive agent was associated with a lower risk of serious infection than a tumor necrosis factor (TNF) antagonist alone or an anti-TNF plus an immunosuppressive agent, according to a meta-analysis.
The primary outcome of the retrospective cohort study was postcolonoscopy colorectal cancer within three years, defined as colorectal cancer diagnosed within six and 36 months after negative findings on index colonoscopy.
This month's quiz asks readers to determine the next step in management for a 64-year-old man with hepatitis C virus (HCV)-related decompensation.
Genotypic resistance–guided and medication-guided therapies did not differ for eradicating refractory H pylori
Patients with Helicobacter pylori infection had similar cure rates with resistance-guided and medication-guided therapy, an unexpected finding, according to an ACP Journal Club commentary.
Cholecystectomy reduced major complications vs catheter drainage in high-risk patients with acute cholecystitis
A Dutch trial showed that older patients without life-threatening comorbidities may benefit from early surgical intervention, but the results would be more generalizable if the study had included patients from a broader age range, an ACP Journal Club commentary said.
The updated guideline from the American College of Gastroenterology offers recommendations on drug treatment and cancer screening, among other topics.
Fecal immunochemical tests (FITs) are noninvasive, easy to prepare, and inexpensive and are as effective as colonoscopy when used in a consistent fashion to screen for colorectal cancer, an editorial stated.